Company Filing History:
5 out of 1,292 
4 out of 160 
1 out of 832,966 Years Active: 1993-2003
Title: Wallich Reinhard: Innovator in Vaccine Development
Introduction
Wallich Reinhard is a prominent inventor based in Heidelberg, Germany. He has made significant contributions to the field of vaccine development, particularly in combating Lyme disease. With a total of 6 patents to his name, Reinhard's work has the potential to impact public health positively.
Latest Patents
Reinhard's latest patents focus on innovative vaccines against Lyme disease. One of his notable inventions provides a vaccine that contains one or more monoclonal antibodies specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. This invention also outlines a process for obtaining the vaccine, along with new monoclonal antibodies and antigens. Another patent emphasizes hybridomas producing antibodies specific for Lyme disease antigens OspA, further enhancing the potential for effective vaccination against this disease.
Career Highlights
Throughout his career, Reinhard has worked with esteemed organizations such as the Max Planck Society for the Advancement of Science and the German Cancer Research Center. His experience in these institutions has allowed him to collaborate with leading experts in the field, contributing to his innovative research and development efforts.
Collaborations
Reinhard has collaborated with notable colleagues, including Markus M. Simon and Ulrich E. Schaible. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in vaccine research.
Conclusion
Wallich Reinhard's contributions to vaccine development, particularly against Lyme disease, highlight his innovative spirit and dedication to public health. His patents and collaborations reflect a commitment to advancing medical science and improving health outcomes.